Brexpiprazole
Psychiatric Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.Small moleculePhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Psychiatric Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Liraglutide Anders Fink-Jensen, MD, DMSci | Phase 4 | BB |
Simvastatin Mclean Hospital | Phase 4 | BB |
Losartan Mclean Hospital | Phase 4 | BB |
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Bo Hu | Phase 2/3 | B |
Rituximab University Hospital, Bordeaux | Phase 3 | B |
View all 15 →
Same molecule, other indications
Brexpiprazole is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →